Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Srivastava Sam
CEO | Chief Executive Officer | - | - |
Nicholas Slack
PSD | President | 41 | 12-06-30 |
Ian Neilson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Lindsay McNair
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Forster
CMP | Compliance Officer | - | - |
Lisa Calicchio
HRO | Human Resources Officer | - | - |
Marco Capasso
LAW | General Counsel | - | - |
General Counsel | 54 | 21-03-31 | |
Treasurer | 41 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Baumer
BRD | Director/Board Member | 56 | 18-12-31 |
Eugene Gorbach
BRD | Director/Board Member | 47 | 11-12-31 |
Stephen McLean
BRD | Director/Board Member | 66 | 11-12-31 |
James Rothman
BRD | Director/Board Member | 74 | 12-01-31 |
Richard Pilnik
BRD | Director/Board Member | 67 | 21-03-31 |
Director/Board Member | - | 11-12-31 | |
Kavita Patel
BRD | Director/Board Member | 50 | 20-10-31 |
Director/Board Member | 48 | 19-12-31 | |
Peter Zippelius
BRD | Director/Board Member | 45 | 18-12-31 |
Director/Board Member | - | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.56% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- WCGC Stock
- Company WCG Clinical, Inc.